Charles Ruprecht
Director
Charlie is an experienced investment professional with corporate finance experience, in Healthcare and Consumer.
Having joined GHO in 2022, Charlie works closely with the management team at Velocity Clinical Research.
Prior to GHO, Charlie was a VP at Webster Equity Partners where he was responsible for sourcing, evaluating, and executing deals across healthcare services and outsourced pharma. Charlie started his career in investment banking at Bank of America Merrill Lynch, where he advised clients across M&A, leveraged finance, and equity IPOs.
Charlie holds a Bachelor of Science from Boston University.